Extended Treatment of Venous Thromboembolism with Reduced-Dose versus Full-Dose Direct Oral Anticoagulants in Patients at High Risk of Recurrence: A Non-Inferiority, Multicentre, Randomised, Open-Label, Blinded Endpoint Trial
Couturaud F, Schmidt J, Sanchez O, et al; RENOVE Investigators. Lancet. 2025. 405(10480):725-735. doi: 10.1016/S0140-6736(24)02842-3.
Abstrak
(Konten ini khusus untuk dokter. Registrasi untuk baca selengkapnya)